Efficacy and Safety Research of Cold Snare Polypectomy and Hot Snare Polypectomy in the Treatment of 4-9 mm Diameter Colorectal 0-Isp and 0-Ip Polyps: a Prospective, Multicenter, Randomized Controlled Study(FAST -REST Study)

October 24, 2024 updated by: ZOU DUOWU, Ruijin Hospital
This study will evaluate the efficacy and safety of cold snare polypectomy(CSP) and hot snare polypectomy(HSP) in the treatment of colorectal 4-9mm 0-Isp and 0-Ip polyps, and compare the complete resection rate, postoperative late bleeding rate, intraoperative bleeding rate, en bloc resection rate, operation time and the number of metal clips used. The conclusion of this study will help clinical doctor develop more effective resection strategies for colorectal 0-Isp and 0-Ip polyps, and provide more effective treatment for patients.

Study Overview

Detailed Description

Colorectal polyps are one of the precancerous lesions of colorectal cancer, 60-80% of which eventually become advanced colorectal cancer. Therefore, early resection of colorectal polyps can effectively reduce the incidence of colorectal cancer. Polyps under white light are judged mainly according to the shape, size and color of polyps. At present, the Paris classification is often used to divide 0-I uplifted polyps into sessile polyps (0-Is), sessile-pedunculated polyps (0-Isp) and pedunculated polyps (0-Ip). It is generally believed that there are thick arteries in 0-Ip polyps, especially thick pedunculated polyps, which are prone to uncontrollable bleeding during operation. 0-Is polyps have small scattered blood vessels and low intraoperative bleeding risk, while the morphological and structural characteristics of 0-Isp polyps are between the two. The current guidelines recommend HSP for 0-Isp and 0-Ip polyps <1 cm, but the internal blood vessels of these polyps are not thick. There is no guidance on whether they can be resected by CSP method, and there is a lack of prospective large sample clinical research. This study will include0-Isp /0-Ip polyps <1cm, and observe the safety and effectiveness of CSP for the above polyp resection , so as to provide reference for the clinical treatment of colorectal polyps.

Study Type

Interventional

Enrollment (Estimated)

982

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200025
        • Department of Gastroenterolog, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age: 18-80 years old, male or female
  2. At least one polyp with size of 4-9 mm 0-Isp or 0-Ip is found during colonoscopy
  3. Voluntarily sign informed consent for endoscopic treatment

Exclusion Criteria:

  1. Boston Bowel Preparation Scale<6 points.
  2. Patients who receive antiplatelet/anticoagulant therapy within 5 days before polypectomy.
  3. Participants with a contraindication to colonoscopy and polypectomy.
  4. Patients with inflammatory bowel disease or gastrointestinal polyposis.
  5. Lesions with submucosal invasion and those suspected of being cancerous at the preprocedural diagnostic evaluation.
  6. Patients with pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: cold snare polypectomy group
  1. Rotate the lens body to make the polyp at about 6 o'clock.
  2. Place the special cold snare in the normal mucosa 1-2mm away from the polyp edge.
  3. Tighten the snare at a constant speed and gently lift it up.
  4. Excision.
  5. According to the polyp size, use the colonoscope suction channel or directly use the snare to pull out the tissue for further pathological examination.
  6. Piecemeal resection will be performed if the en-bloc resection fails.
Place the special cold snare in the normal mucosa 1-2mm away from the polyp edge. Tighten the snare at a constant speed and gently lift it up and then excision.
Other Names:
  • CSP
Other: hot snare polypectomy group
  1. Rotate the lens body to make the polyp at about 6 o'clock.
  2. According to evaluation of the polyps, directly place the snare on the edge of the polyp including a clear margin of normal tissue (1-2 mm) or after submucosal injection.
  3. Tighten the snare at a constant speed and gently lift it up.
  4. Use the electrocoagulation and electroscission mode, power on for several seconds until the polyp is cut off.
  5. According to the polyp size, use the colonoscope suction channel or directly use the snare to pull out the tissue for further pathological examination.
  6. Piecemeal resection will be performed if the en-bloc resection fails.
According to evaluation of the polyps, directly place the snare on the edge of the polyp including a clear margin of normal tissue (1-2 mm) or after submucosal injection. Tighten the snare at a constant speed and gently lift it up.Use the electrocoagulation and electroscission mode, power on for several seconds until the polyp is cut off.
Other Names:
  • HSP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complete resection rate
Time Frame: Up to 5-7 days from operation day
The polyps and the two biopsies from the margin will be sent to the pathologist for further analysis. Two independent experienced pathologists will evaluate the samples separately and both are blinded to the technique performed for polypectomy. Complete resection rate is defined as the negative pathological evaluation of two biopsies obtained from the margin.
Up to 5-7 days from operation day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative delayed bleeding rate
Time Frame: Up to 14 days from operation day
Incidence of bleeding requiring endoscopic hemostasis intervention within 14 days after surgery
Up to 14 days from operation day
Intraoperative bleeding rate
Time Frame: Up to 1 minute from the time the polyp is resected
Immediate bleeding is defined as bleeding persists >60s after polypectomy according to the ESGE recommendations (2017) and requires for endoscopic intervention.
Up to 1 minute from the time the polyp is resected
En bloc resection rate
Time Frame: Up to 7 days when the pathologists finish the evaluations.
The lesion is removed at one time, and the integrity of the specimen is maintained
Up to 7 days when the pathologists finish the evaluations.
Operation time
Time Frame: From the snare/ injection needle exits the working channel to leaving the wound.
CSP: the time from the time the snare exits the working channel to leaving the wound. Hsp: time from the injection needle leaving the working channel to leaving the wound
From the snare/ injection needle exits the working channel to leaving the wound.
Other related postoperative complications
Time Frame: Up to 48 Hours from the time the polyp is resected
Perforation, infection, electrocoagulation syndrome, etc
Up to 48 Hours from the time the polyp is resected
Number of metal clips used
Time Frame: The time when the operation is completed
Whether metal clips are used for hemostasis, and the number of metal clips
The time when the operation is completed

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 15, 2024

Primary Completion (Estimated)

February 1, 2026

Study Completion (Estimated)

March 1, 2026

Study Registration Dates

First Submitted

July 18, 2024

First Submitted That Met QC Criteria

October 24, 2024

First Posted (Actual)

October 26, 2024

Study Record Updates

Last Update Posted (Actual)

October 26, 2024

Last Update Submitted That Met QC Criteria

October 24, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RuijinH20241532

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Polyps of Colon

Clinical Trials on cold snare polypectomy

Subscribe